The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy – characterized by some benefit but only rare durable responses – was the only treatment option for patients with NSCLC w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Brahmer, Julie R., Govindan, Ramaswamy, Anders, Robert A., Antonia, Scott J., Sagorsky, Sarah, Davies, Marianne J., Dubinett, Steven M., Ferris, Andrea, Gandhi, Leena, Garon, Edward B., Hellmann, Matthew D., Hirsch, Fred R., Malik, Shakuntala, Neal, Joel W., Papadimitrakopoulou, Vassiliki A., Rimm, David L., Schwartz, Lawrence H., Sepesi, Boris, Yeap, Beow Yong, Rizvi, Naiyer A., Herbst, Roy S.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Position Article and Guidelines
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048854/
https://ncbi.nlm.nih.gov/pubmed/30012210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0382-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky